Healthcare Realty Trust (HR) Financials

$14.56 +0.21 (+1.46%)

Closing price 05/27/2025 03:59 PM Eastern

Extended Trading

$14.77 +0.21 (+1.44%)

As of 04:01 AM Eastern

Annual Income Statements for Healthcare Realty Trust

This table shows Healthcare Realty Trust's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	-654	-278	41	67	72	30	213	64	46	33
Consolidated Net Income / (Loss)	-664	-282	41	67	72	31	218	66	47	34
Net Income / (Loss) Continuing Operations	-664	-282	41	67	72	31	218	66	47	34
Total Pre-Tax Income	-664	-282	41	67	72	29	216	65	47	33
Total Operating Income	33	54	-24	82	79	146	151	161	111	94
Total Gross Profit	795	843	589	323	303	481	696	614	317	280
Total Revenue	1,268	1,344	933	535	500	692	696	614	461	404
Operating Revenue	1,268	1,344	933	535	500	692	696	614	461	404
Total Cost of Revenue	473	500	344	212	197	211	0.00	0.00	144	123
Operating Cost of Revenue	473	500	344	212	197	211	-	0.00	144	123
Total Operating Expenses	761	789	612	241	224	334	545	453	206	187
Selling, General & Admin Expense	83	58	53	34	31	41	35	33	29	26
Depreciation Expense	675	731	453	203	190	290	280	245	177	154
Other Operating Expenses / (Income)	0.00	-1.95	103	0.00	0.00	2.35	222	198	6.54	4.56
Restructuring Charge	3.12	2.03	3.23	3.93	2.56	-	-	-	-	-
Total Other Income / (Expense), net	-697	-336	65	-15	-7.22	-117	65	-97	-64	-60
Interest Expense	243	259	149	53	78	118	102	97	65	58
Interest & Investment Income	-0.14	-1.68	-0.69	-0.80	-0.46	-	-	-	-	-
Other Income / (Expense), net	-455	-76	214	39	71	0.84	166	0.03	1.63	-2.20
Net Income / (Loss) Attributable to Noncontrolling Interest	-9.42	-3.82	-0.20	0.00	0.00	0.60	4.16	1.66	1.43	0.63
Basic Earnings per Share	($1.81)	($0.74)	$0.15	$0.45	$0.52	$0.15	$1.04	$0.35	$0.34	$0.26
Weighted Average Basic Shares Outstanding	365.55M	378.93M	252.36M	142.64M	133.93M	205.72M	206.07M	181.06M	136.62M	126.07M
Diluted Earnings per Share	($1.81)	($0.74)	$0.15	$0.45	$0.52	$0.14	$1.02	$0.34	$0.33	$0.26
Weighted Average Diluted Shares Outstanding	365.55M	378.93M	253.87M	142.71M	134.01M	209.61M	210.06M	185.28M	140.26M	128.00M
Weighted Average Basic & Diluted Shares Outstanding	350.82M	381.18M	380.78M	229.03M	218.75M	216.69M	205.06M	205.05M	141.72M	-
Cash Dividends to Common per Share	$1.24	$1.24	$1.24	$1.21	$1.27	$1.25	$1.23	$1.21	$1.19	$1.17

This table shows Healthcare Realty Trust's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-45	-107	-93	-144	-311	-41	-68	-83	-87	-36	28
Consolidated Net Income / (Loss)	-45	-108	-95	-146	-315	-42	-69	-84	-88	-36	29
Net Income / (Loss) Continuing Operations	-45	-108	-95	-146	-315	-42	-69	-84	-88	-36	29
Total Pre-Tax Income	-45	-108	-95	-146	-315	-42	-69	-84	-88	-36	29
Total Operating Income	19	250	11	11	-238	13	6.02	29	6.33	10	-61
Total Gross Profit	184	195	195	199	206	209	211	213	211	221	194
Total Revenue	299	310	315	316	327	330	342	338	333	338	306
Operating Revenue	299	310	315	316	327	330	342	338	333	338	306
Total Cost of Revenue	115	114	120	118	121	121	132	125	122	117	112
Operating Cost of Revenue	115	114	120	118	121	121	132	125	122	117	112
Total Operating Expenses	166	-54	184	188	444	196	205	184	205	210	255
Selling, General & Admin Expense	14	34	20	14	15	15	13	15	15	14	17
Depreciation Expense	151	160	163	173	178	180	183	183	184	185	158
Restructuring Charge	1.01	1.58	0.72	0.43	0.40	0.30	0.77	0.67	0.29	0.09	0.48
Total Other Income / (Expense), net	-64	-358	-106	-157	-77	-54	-75	-113	-94	-47	89
Interest Expense	55	59	61	62	61	63	66	65	64	64	54
Interest & Investment Income	0.00	0.23	0.21	-0.15	-0.42	-0.43	-0.46	-0.02	-0.78	0.09	-0.12
Other Income / (Expense), net	-9.08	-300	-45	-94	-16	9.24	-7.92	-47	-30	17	144
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.52	-1.37	-1.51	-2.16	-4.38	-1.14	-0.76	-0.97	-0.95	-0.52	0.31
Basic Earnings per Share	($0.13)	($0.34)	($0.26)	($0.39)	($0.82)	($0.11)	($0.18)	($0.22)	($0.23)	($0.25)	$0.08
Weighted Average Basic Shares Outstanding	349.54M	365.55M	358.96M	372.48M	379.45M	378.93M	378.93M	378.90M	378.84M	252.36M	328.81M
Diluted Earnings per Share	($0.13)	($0.34)	($0.26)	($0.39)	($0.82)	($0.11)	($0.18)	($0.22)	($0.23)	($0.25)	$0.08
Weighted Average Diluted Shares Outstanding	349.54M	365.55M	358.96M	372.48M	379.45M	378.93M	378.93M	378.90M	378.84M	253.87M	332.03M
Weighted Average Basic & Diluted Shares Outstanding	351.42M	350.82M	354.39M	363.03M	378.54M	381.18M	380.87M	380.86M	380.82M	380.78M	380.57M
Cash Dividends to Common per Share	$0.31	$0.31	$0.31	$0.31	$0.31	$0.31	$0.31	$0.31	$0.31	-	$0.31

This table details how cash moves in and out of Healthcare Realty Trust's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	43	-35	48	-2.13	15	-96	15	94	-3.92	-2.25
Net Cash From Operating Activities	502	500	273	233	470	340	337	308	204	191
Net Cash From Continuing Operating Activities	502	500	273	233	470	340	337	308	204	191
Net Income / (Loss) Continuing Operations	-664	-282	41	67	72	31	218	66	47	34
Consolidated Net Income / (Loss)	-664	-282	41	67	72	31	218	66	47	34
Depreciation Expense	675	731	453	203	190	281	271	239	175	152
Amortization Expense	21	13	4.57	-0.51	2.14	-	-	-	-	-
Non-Cash Adjustments To Reconcile Net Income	495	110	-193	-28	206	33	-147	-6.73	2.87	9.63
Changes in Operating Assets and Liabilities, net	-26	-71	-33	-8.53	-0.85	-4.41	-5.02	9.66	-22	-3.70
Net Cash From Investing Activities	901	349	1,634	-562	-555	-667	176	-2,455	-608	-274
Net Cash From Continuing Investing Activities	901	349	1,634	-562	-555	-667	176	-2,455	-608	-274
Purchase of Property, Plant & Equipment	-249	-280	-566	-467	-491	-645	-95	-2,448	-635	-309
Acquisitions	0.00	-3.82	-100	-90	-66	-	-	-69	0.00	0.00
Purchase of Investments	-0.51	-1.80	-1.00	-186	0.00	0.00	-	-	-	-
Sale of Property, Plant & Equipment	1,226	701	1,203	184	4.90	0.00	-	81	27	35
Other Investing Activities, net	-76	-66	1,099	-4.03	-3.09	-23	271	-28	0.00	-0.20
Net Cash From Financing Activities	-1,359	-884	-1,859	328	100	231	-499	2,241	401	81
Net Cash From Continuing Financing Activities	-1,359	-884	-1,859	328	100	231	-499	2,241	401	81
Repayment of Debt	-376	-405	-1,136	-25	-617	-1,334	-389	-762	-973	-367
Repurchase of Common Equity	-520	-2.30	-3.19	-3.80	-1.44	-12	-70	-3.41	-7.21	-1.67
Payment of Dividends	-463	-477	-285	-175	-163	-265	-258	-212	-163	-149
Issuance of Debt	0.00	0.00	667	210	747	1,517	145	1,470	1,122	554
Issuance of Common Equity	0.10	0.13	23	331	142	325	73	1,747	422	44
Other Financing Activities, net	-0.02	-0.02	-1,124	-9.18	-7.68	0.00	-	2.42	0.92	-0.24
Cash Interest Paid	207	219	114	50	54	-	-	-	-	-

This table details how cash moves in and out of Healthcare Realty Trust's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-43	43	-16	16	0.47	1.03	-11	-14	-11	3.38	23
Net Cash From Operating Activities	48	138	119	168	76	127	118	185	69	146	13
Net Cash From Continuing Operating Activities	48	138	119	168	76	127	118	185	69	146	13
Net Income / (Loss) Continuing Operations	-45	-108	-95	-146	-315	-42	-69	-84	-88	-36	29
Consolidated Net Income / (Loss)	-45	-108	-95	-146	-315	-42	-69	-84	-88	-36	29
Depreciation Expense	151	160	163	173	178	180	183	183	184	185	158
Amortization Expense	4.80	3.97	5.89	6.99	4.20	3.49	1.95	4.30	2.86	2.95	1.48
Non-Cash Adjustments To Reconcile Net Income	16	71	54	98	272	7.00	12	53	37	-15	-134
Changes in Operating Assets and Liabilities, net	-78	11	-9.23	35	-62	-22	-9.92	28	-67	8.86	-42
Net Cash From Investing Activities	-39	419	331	210	-59	237	119	-48	42	209	1,707
Net Cash From Continuing Investing Activities	-39	419	331	210	-59	237	118	-48	42	209	1,707
Purchase of Property, Plant & Equipment	-69	-62	-69	-67	-50	-75	-72	-42	-91	-91	-142
Acquisitions	-0.85	-	-	-	0.00	-	-	-	-3.82	-0.38	-50
Purchase of Investments	-0.00	-0.49	-0.02	-	0.00	-1.49	0.47	-0.48	-0.30	-1.00	-
Sale of Property, Plant & Equipment	35	502	420	304	0.50	335	206	11	150	331	763
Other Investing Activities, net	-3.41	-21	-20	-26	-8.69	-21	-17	-16	-13	-30	1,136
Net Cash From Financing Activities	-52	-514	-466	-363	-17	-363	-248	-151	-122	-351	-1,696
Net Cash From Continuing Financing Activities	-52	-514	-466	-363	-17	-363	-248	-151	-122	-351	-1,696
Repayment of Debt	-35	-100	-407	149	-17	-392	20	-32	-0.67	-1,051	-65
Repurchase of Common Equity	-0.55	-96	-151	-273	-0.32	-0.46	0.01	-0.11	-1.73	-2.30	-0.04
Payment of Dividends	-110	-112	-114	-119	-119	-119	-119	-119	-119	1,004	-1,196
Issuance of Debt	94	-206	-	-	120	149	-	-	0.00	821	-435
Issuance of Common Equity	0.00	-	-	-	0.10	0.02	0.03	0.03	0.05	0.05	0.08
Other Financing Activities, net	-0.14	-0.00	0.02	0.08	-0.11	-0.01	0.03	0.06	-0.10	-1,124	0.05
Cash Interest Paid	68	26	75	31	74	32	79	33	76	30	57

This table presents Healthcare Realty Trust's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	10,651	12,637	13,850	4,259	6,791	6,188	6,450	3,748	3,172
Total Current Assets	69	26	61	13	119	126	100	11	13
Cash & Equivalents	69	26	61	13	115	126	100	11	13
Plant, Property, & Equipment, net	8,409	10,153	11,222	3,403	5,482	5,061	5,294	3,035	2,529
Plant, Property & Equipment, gross	10,892	12,380	12,868	4,741	7,184	6,269	6,316	3,853	3,205
Accumulated Depreciation	2,484	2,227	1,645	1,339	1,703	1,208	1,022	818	676
Total Noncurrent Assets	2,096	2,335	2,446	812	1,190	1,001	1,055	701	631
Long-Term Investments	473	312	327	162	64	67	69	0.00	-
Noncurrent Note & Lease Receivables	124	-	-	187	-	-	-	-	-
Goodwill	0.00	251	223	3.49	-	-	-	-	-
Intangible Assets	665	836	960	120	639	699	746	514	473
Other Noncurrent Operating Assets	834	937	936	339	487	236	240	187	158
Total Liabilities & Shareholders' Equity	10,651	12,637	13,850	4,259	6,791	6,188	6,450	3,748	3,172
Total Liabilities	5,345	5,714	6,168	2,074	3,556	2,847	3,079	1,963	1,761
Total Current Liabilities	223	212	244	86	200	185	168	105	95
Accounts Payable	223	212	244	86	200	185	168	105	95
Total Noncurrent Liabilities	5,045	5,502	5,924	1,956	3,355	2,662	2,912	1,858	1,666
Long-Term Debt	4,663	4,995	5,352	1,801	3,027	2,541	2,781	1,769	1,591
Capital Lease Obligations	-5.00	230	-	-9.03	198	-	-	-	-
Other Noncurrent Operating Liabilities	386	277	572	164	130	61	69	39	75
Other Noncurrent Nonoperating Liabilities	1.28	0.30	0.44	0.29	-	-	-	-	-
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	4.78	3.87	2.01	0.00	0.00	6.54	6.74	4.65	4.44
Total Equity & Noncontrolling Interests	5,301	6,919	7,680	2,185	3,235	3,335	3,363	1,780	1,407
Total Preferred & Common Equity	5,235	6,823	7,571	2,185	3,174	3,256	3,279	1,687	1,379
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	5,235	6,823	7,571	2,185	3,174	3,256	3,279	1,687	1,379
Common Stock	9,122	9,606	9,591	3,974	4,919	4,528	4,511	2,756	2,330
Retained Earnings	-4,260	-	-	-3,045	-	-	-	-	-
Accumulated Other Comprehensive Income / (Loss)	-1.17	-11	2.14	-9.98	-17	0.31	0.27	0.00	-
Other Equity Adjustments	374	-2,773	-2,023	1,266	-1,728	-1,272	-1,232	-1,069	-951
Noncontrolling Interest	66	96	109	0.00	61	79	85	93	28

This table presents Healthcare Realty Trust's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	10,496	11,245	11,804	12,281	13,104	13,394	13,569	14,195
Total Current Assets	26	23	42	26	25	36	171	177
Cash & Equivalents	26	23	42	26	25	36	50	58
Plant, Property, & Equipment, net	8,326	8,926	9,406	9,966	10,393	10,725	10,894	11,512
Plant, Property & Equipment, gross	10,910	11,405	11,834	12,340	12,487	12,709	12,704	12,981
Accumulated Depreciation	2,584	2,479	2,428	2,374	2,094	1,984	1,810	1,469
Total Noncurrent Assets	2,068	2,218	2,274	2,167	2,565	2,512	2,504	2,507
Long-Term Investments	470	417	375	310	325	327	328	328
Noncurrent Note & Lease Receivables	124	123	122	-	-	-	-	-
Intangible Assets	632	718	765	816	890	922	929	969
Other Noncurrent Operating Assets	842	959	1,012	1,040	1,098	1,012	986	1,061
Total Liabilities & Shareholders' Equity	10,496	11,245	11,804	12,281	13,104	13,394	13,569	14,195
Total Liabilities	5,349	5,645	5,829	5,774	5,995	6,108	6,102	6,356
Total Current Liabilities	145	205	198	163	205	196	155	231
Accounts Payable	145	197	196	163	205	196	155	231
Other Current Nonoperating Liabilities	0.42	7.92	1.81	-	-	-	-	-
Total Noncurrent Liabilities	5,127	5,362	5,550	5,611	5,790	5,912	5,947	6,125
Long-Term Debt	4,733	4,958	5,148	5,108	5,227	5,340	5,362	5,570
Capital Lease Obligations	-4.37	-5.84	-6.20	-	-	-	-	-
Other Noncurrent Operating Liabilities	399	410	408	502	559	572	585	545
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	4.63	3.88	3.88	3.88	3.20	2.49	2.00	-
Total Equity & Noncontrolling Interests	5,142	5,595	5,971	6,503	7,106	7,283	7,465	7,839
Total Preferred & Common Equity	5,078	5,515	5,887	6,416	7,004	7,179	7,359	7,727
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	5,078	5,515	5,887	6,416	7,004	7,179	7,359	7,727
Common Stock	9,125	9,202	9,344	9,613	9,601	9,599	9,595	9,590
Retained Earnings	-4,369	-4,150	-4,038	-	-	-	-	-
Accumulated Other Comprehensive Income / (Loss)	-7.21	-17	6.99	4.79	17	9.33	-8.55	5.52
Other Equity Adjustments	329	481	574	-3,202	-2,615	-2,429	-2,228	-1,869
Noncontrolling Interest	64	80	84	87	102	104	106	112

This table displays calculated financial ratios and metrics derived from Healthcare Realty Trust's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-5.62%	44.08%	74.38%	7.04%	-27.80%	-0.63%	13.43%	33.21%	14.14%	8.70%
EBITDA Growth	-61.87%	11.31%	100.79%	-5.87%	-19.90%	-27.31%	47.04%	39.17%	18.44%	11.76%
EBIT Growth	-1,824.71%	-111.49%	57.97%	-19.79%	2.16%	-53.65%	96.62%	43.52%	23.12%	13.88%
NOPAT Growth	-38.17%	259.07%	-129.15%	2.94%	-45.72%	-3.16%	-6.41%	45.60%	18.49%	12.65%
Net Income Growth	-135.36%	-793.20%	-38.95%	-7.67%	134.72%	-85.87%	231.86%	38.51%	41.09%	-27.04%
EPS Growth	-144.59%	-593.33%	-66.67%	-13.46%	271.43%	-86.27%	200.00%	3.03%	26.92%	-29.73%
Operating Cash Flow Growth	0.36%	83.25%	17.25%	-50.51%	38.10%	0.89%	9.71%	50.98%	6.59%	13.41%
Free Cash Flow Firm Growth	161.32%	110.01%	-442.17%	146.43%	-207.04%	1,058.21%	119.49%	-414.43%	-1,783.77%	88.69%
Invested Capital Growth	-19.38%	-6.69%	229.40%	-39.42%	806.76%	-87.83%	-4.90%	68.86%	18.53%	4.08%
Revenue Q/Q Growth	-1.60%	-0.56%	39.23%	31.33%	-31.39%	0.58%	-0.21%	9.20%	4.53%	1.78%
EBITDA Q/Q Growth	-24.88%	-1.45%	26.66%	29.12%	-22.92%	0.93%	-5.12%	15.69%	7.50%	8.25%
EBIT Q/Q Growth	-20.58%	-37.91%	0.17%	0.08%	-3.28%	-3.76%	-8.54%	23.66%	12.41%	20.64%
NOPAT Q/Q Growth	116.44%	4.26%	39.47%	87.04%	-48.79%	1,134.31%	-56.57%	27.97%	9.38%	1.32%
Net Income Q/Q Growth	-11.14%	-1.95%	-59.39%	-26.54%	112.93%	-17.60%	-11.35%	67.04%	16.14%	-24.49%
EPS Q/Q Growth	-14.56%	15.91%	-75.41%	-30.77%	246.67%	-22.22%	-11.30%	78.95%	13.79%	-23.53%
Operating Cash Flow Q/Q Growth	2.18%	-3.62%	44.29%	-37.24%	26.48%	1.60%	5.52%	8.30%	1.50%	7.59%
Free Cash Flow Firm Q/Q Growth	42.39%	-27.14%	-28.39%	1,432.12%	-7,816.55%	8,888.74%	-30.09%	5.50%	-5.30%	74.76%
Invested Capital Q/Q Growth	-6.88%	-1.53%	-3.90%	-39.27%	4.17%	-88.07%	-1.17%	-1.02%	1.02%	0.13%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	62.67%	62.76%	63.11%	60.31%	60.67%	69.44%	100.00%	100.00%	68.81%	69.44%
EBITDA Margin	21.69%	53.69%	69.49%	60.35%	68.63%	61.86%	84.57%	65.23%	62.44%	60.18%
Operating Margin	2.64%	4.03%	-2.55%	15.29%	15.89%	21.14%	21.70%	26.30%	24.06%	23.17%
EBIT Margin	-33.20%	-1.63%	20.42%	22.55%	30.09%	21.26%	45.59%	26.30%	24.41%	22.63%
Profit (Net Income) Margin	-52.35%	-20.99%	4.36%	12.46%	14.45%	4.44%	31.25%	10.68%	10.27%	8.31%
Tax Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	106.52%	100.80%	101.21%	100.00%	100.46%
Interest Burden Percent	157.66%	1,289.29%	21.36%	55.28%	48.02%	19.62%	68.00%	40.13%	42.08%	36.55%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.22%	0.31%	-0.29%	1.62%	2.28%	4.59%	2.59%	3.39%	3.40%	3.19%
ROIC Less NNEP Spread (ROIC-NNEP)	-15.26%	-6.35%	1.71%	0.97%	-2.47%	63.76%	5.27%	-1.00%	-0.41%	-0.85%
Return on Net Nonoperating Assets (RNNOA)	-11.08%	-4.18%	1.12%	0.84%	-0.11%	-3.68%	3.90%	-0.85%	-0.43%	-0.87%
Return on Equity (ROE)	-10.86%	-3.86%	0.82%	2.46%	2.17%	0.91%	6.49%	2.54%	2.96%	2.32%
Cash Return on Invested Capital (CROIC)	21.68%	7.23%	-107.14%	50.72%	-157.99%	161.19%	7.61%	-47.83%	-13.56%	-0.80%
Operating Return on Assets (OROA)	-3.62%	-0.17%	2.10%	2.18%	2.24%	2.29%	5.02%	3.17%	3.25%	2.95%
Return on Assets (ROA)	-5.70%	-2.13%	0.45%	1.21%	1.08%	0.48%	3.44%	1.29%	1.37%	1.08%
Return on Common Equity (ROCE)	-10.71%	-3.81%	0.82%	2.43%	1.03%	0.44%	6.31%	2.45%	2.84%	2.27%
Return on Equity Simple (ROE_SIMPLE)	-12.68%	-4.13%	0.54%	3.05%	2.27%	0.00%	6.68%	2.00%	2.81%	2.43%
Net Operating Profit after Tax (NOPAT)	23	38	-24	82	79	146	151	161	111	94
NOPAT Margin	1.85%	2.82%	-2.55%	15.29%	15.89%	21.14%	21.70%	26.30%	24.06%	23.17%
Net Nonoperating Expense Percent (NNEP)	15.48%	6.66%	-2.00%	0.65%	4.75%	-59.18%	-2.68%	4.39%	3.81%	4.04%
Return On Investment Capital (ROIC_SIMPLE)	0.24%	0.31%	-0.18%	2.06%	1.23%	2.37%	2.57%	2.63%	3.12%	3.12%
Cost of Revenue to Revenue	37.33%	37.24%	36.89%	39.69%	39.33%	30.56%	0.00%	0.00%	31.19%	30.56%
SG&A Expenses to Revenue	6.55%	4.35%	5.65%	6.39%	6.15%	5.98%	5.05%	5.44%	6.24%	6.33%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	60.03%	58.73%	65.67%	45.02%	44.77%	48.30%	78.30%	73.70%	44.76%	46.27%
Earnings before Interest and Taxes (EBIT)	-421	-22	190	121	150	147	317	161	113	91
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	275	721	648	323	343	428	589	401	288	243
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.16	0.87	0.55	1.46	0.74	1.17	0.96	0.96	1.31	1.30
Price to Tangible Book Value (P/TBV)	1.33	1.03	0.65	1.55	0.93	1.44	1.23	1.24	1.88	1.98
Price to Revenue (P/Rev)	4.80	4.41	4.44	5.98	4.73	5.66	4.51	5.11	4.80	4.45
Price to Earnings (P/E)	0.00	0.00	101.23	47.95	32.75	129.89	14.71	49.07	48.17	54.62
Dividend Yield	7.45%	7.93%	32.13%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.99%	2.09%	3.05%	0.77%	6.80%	2.04%	2.08%	1.83%
Enterprise Value to Invested Capital (EV/IC)	1.09	0.93	0.74	1.27	0.87	9.59	0.98	0.98	1.15	1.14
Enterprise Value to Revenue (EV/Rev)	8.10	8.12	9.88	9.00	10.94	9.60	8.00	9.51	8.82	8.44
Enterprise Value to EBITDA (EV/EBITDA)	37.34	15.13	14.22	14.91	15.94	15.51	9.46	14.58	14.13	14.03
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	48.38	39.92	36.37	45.13	17.56	36.17	36.15	37.29
Enterprise Value to NOPAT (EV/NOPAT)	438.29	287.99	0.00	58.88	68.84	45.38	36.89	36.17	36.68	36.42
Enterprise Value to Operating Cash Flow (EV/OCF)	20.48	21.84	33.78	20.69	11.63	19.51	16.52	18.99	19.97	17.84
Enterprise Value to Free Cash Flow (EV/FCFF)	4.49	12.46	0.00	1.88	0.00	1.29	12.55	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.88	0.75	0.70	0.82	1.00	0.80	0.76	0.83	0.99	1.13
Long-Term Debt to Equity	0.88	0.75	0.70	0.82	1.00	0.80	0.76	0.83	0.99	1.13
Financial Leverage	0.73	0.66	0.65	0.86	0.05	-0.06	0.74	0.85	1.04	1.03
Leverage Ratio	1.90	1.81	1.84	2.04	2.01	1.89	1.88	1.98	2.16	2.15
Compound Leverage Factor	3.00	23.38	0.39	1.13	0.97	0.37	1.28	0.79	0.91	0.78
Debt to Total Capital	46.75%	43.01%	41.06%	45.06%	49.93%	44.49%	43.20%	45.21%	49.77%	52.99%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	46.75%	43.01%	41.06%	45.06%	49.93%	44.49%	43.20%	45.21%	49.77%	52.99%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.71%	0.82%	0.85%	0.00%	0.94%	1.18%	1.45%	1.49%	2.75%	1.07%
Common Equity to Total Capital	52.54%	56.17%	58.09%	54.94%	49.13%	0.00%	55.35%	53.30%	47.48%	45.95%
Debt to EBITDA	16.93	7.24	8.26	5.55	9.41	6.42	4.31	6.94	6.15	6.55
Net Debt to EBITDA	14.96	6.77	7.66	5.01	8.87	6.19	3.99	6.52	6.11	6.49
Long-Term Debt to EBITDA	16.93	7.24	8.26	5.55	9.41	6.42	4.31	6.94	6.15	6.55
Debt to NOPAT	198.76	137.85	-224.62	21.92	40.61	18.79	16.82	17.23	15.95	17.00
Net Debt to NOPAT	175.63	128.95	-208.33	19.78	38.31	18.12	15.54	16.18	15.85	16.86
Long-Term Debt to NOPAT	198.76	137.85	-224.62	21.92	40.61	18.79	16.82	17.23	15.95	17.00
Altman Z-Score	0.09	0.71	0.50	0.12	0.53	0.91	0.93	0.78	0.87	0.80
Noncontrolling Interest Sharing Ratio	1.40%	1.44%	1.12%	1.12%	52.38%	51.92%	2.63%	3.67%	4.06%	2.25%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.31	0.12	0.25	0.15	0.59	0.00	0.68	0.60	0.11	0.14
Quick Ratio	0.31	0.12	0.25	0.15	0.58	0.00	0.68	0.60	0.11	0.14
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	2,288	876	-8,747	2,556	-5,505	5,143	444	-2,278	-443	-24
Operating Cash Flow to CapEx	0.00%	0.00%	0.00%	82.37%	96.64%	52.79%	354.19%	12.99%	33.48%	69.75%
Free Cash Flow to Firm to Interest Expense	9.43	3.39	-58.67	48.12	-70.88	43.49	4.37	-23.56	-6.80	-0.41
Operating Cash Flow to Interest Expense	2.07	1.93	1.83	4.38	6.05	2.88	3.32	3.18	3.13	3.30
Operating Cash Flow Less CapEx to Interest Expense	6.09	3.56	6.10	-0.94	-0.21	-2.57	2.38	-21.31	-6.21	-1.43
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.11	0.10	0.10	0.10	0.07	0.11	0.11	0.12	0.13	0.13
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.14	0.13	0.13	0.12	0.00	0.00	0.13	0.15	0.17	0.16
Accounts Payable Turnover	2.18	2.19	2.08	1.48	1.06	1.19	0.00	0.00	1.44	1.26
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	167.49	166.30	175.13	246.29	345.52	307.88	0.00	0.00	253.87	289.86
Cash Conversion Cycle (CCC)	-167.49	-166.30	-175.13	-246.29	-345.52	-307.88	0.00	0.00	-253.87	-289.86
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	9,423	11,688	12,526	3,803	6,277	692	5,689	5,982	3,543	2,989
Invested Capital Turnover	0.12	0.11	0.11	0.11	0.14	0.22	0.12	0.13	0.14	0.14
Increase / (Decrease) in Invested Capital	-2,265	-838	8,723	-2,475	5,585	-4,997	-293	2,440	554	117
Enterprise Value (EV)	10,271	10,915	9,215	4,813	5,467	6,640	5,574	5,840	4,067	3,408
Market Capitalization	6,084	5,927	4,140	3,196	2,364	3,917	3,141	3,137	2,211	1,799
Book Value per Share	$14.77	$17.91	$19.89	$9.89	$14.52	$0.00	$15.73	$16.00	$11.91	$10.86
Tangible Book Value per Share	$12.90	$15.06	$16.78	$9.33	$11.60	$0.00	$12.36	$12.36	$8.28	$7.14
Total Capital	9,964	12,147	13,034	3,977	6,460	6,180	5,883	6,151	3,554	3,002
Total Debt	4,658	5,225	5,352	1,792	3,225	2,750	2,541	2,781	1,769	1,591
Total Long-Term Debt	4,658	5,225	5,352	1,792	3,225	2,750	2,541	2,781	1,769	1,591
Net Debt	4,116	4,887	4,964	1,617	3,042	2,651	2,348	2,612	1,758	1,578
Capital Expenditures (CapEx)	-977	-421	-637	282	486	645	95	2,368	608	274
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-223	-212	-244	-86	-200	-33	-185	-168	-105	-95
Debt-free Net Working Capital (DFNWC)	-154	-186	-183	-73	-82	0.00	-59	-67	-94	-82
Net Working Capital (NWC)	-154	-186	-183	-73	-82	0.00	-59	-67	-94	-82
Net Nonoperating Expense (NNE)	687	320	-65	15	7.22	116	-67	96	64	60
Net Nonoperating Obligations (NNO)	4,117	4,765	4,844	1,617	3,042	-2,738	2,348	2,612	1,758	1,578
Total Depreciation and Amortization (D&A)	696	743	458	202	193	281	271	239	175	152
Debt-free, Cash-free Net Working Capital to Revenue	-17.54%	-15.78%	-26.17%	-16.10%	-40.10%	-4.73%	-26.57%	-27.34%	-22.79%	-23.51%
Debt-free Net Working Capital to Revenue	-12.11%	-13.86%	-19.63%	-13.64%	-16.33%	0.00%	-8.45%	-10.99%	-20.35%	-20.27%
Net Working Capital to Revenue	-12.11%	-13.86%	-19.63%	-13.64%	-16.33%	0.00%	-8.45%	-10.99%	-20.35%	-20.27%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.81)	($0.74)	$0.15	$0.45	$0.24	$0.15	$1.04	$0.35	$0.34	$0.52
Adjusted Weighted Average Basic Shares Outstanding	365.55M	378.93M	252.36M	219.44M	218.08M	205.72M	206.07M	181.06M	136.62M	254.15M
Adjusted Diluted Earnings per Share	($1.81)	($0.74)	$0.15	$0.44	$0.24	$0.14	$1.02	$0.34	$0.33	$0.52
Adjusted Weighted Average Diluted Shares Outstanding	365.55M	378.93M	253.87M	224.22M	221.67M	209.61M	210.06M	185.28M	140.26M	256.08M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	350.82M	381.18M	380.78M	229.03M	218.75M	216.69M	205.06M	205.05M	141.72M	0.00
Normalized Net Operating Profit after Tax (NOPAT)	26	39	-14	60	57	103	112	96	74	67
Normalized NOPAT Margin	2.02%	2.93%	-1.55%	11.21%	11.49%	14.82%	16.08%	15.68%	15.95%	16.67%
Pre Tax Income Margin	-52.35%	-20.99%	4.36%	12.46%	14.45%	4.17%	31.00%	10.55%	10.27%	8.27%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-1.74	-0.08	1.28	2.27	1.94	1.24	3.12	1.67	1.73	1.58
NOPAT to Interest Expense	0.10	0.15	-0.16	1.54	1.02	1.24	1.49	1.67	1.70	1.61
EBIT Less CapEx to Interest Expense	2.29	1.54	5.55	-3.05	-4.33	-4.21	2.19	-22.82	-7.61	-3.15
NOPAT Less CapEx to Interest Expense	4.12	1.78	4.11	-3.78	-5.24	-4.21	0.55	-22.82	-7.63	-3.11
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-69.79%	-169.23%	701.37%	263.21%	225.16%	861.16%	118.52%	323.89%	344.55%	442.61%
Augmented Payout Ratio	-148.12%	-170.04%	709.21%	268.92%	227.15%	900.75%	150.83%	329.09%	359.78%	447.58%

This table displays calculated financial ratios and metrics derived from Healthcare Realty Trust's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-8.52%	-6.26%	-7.84%	-6.45%	-1.84%	-2.25%	11.72%	132.68%	132.99%	349.14%	124.22%
EBITDA Growth	331.26%	-44.34%	-26.23%	-42.56%	-143.61%	-4.91%	-24.51%	117.17%	46.66%	171.22%	289.37%
EBIT Growth	103.71%	-327.58%	-1,688.77%	-353.52%	-977.97%	-21.51%	-102.30%	-183.60%	-140.82%	1.15%	623.74%
NOPAT Growth	48.91%	1,865.73%	84.84%	-63.24%	-3,862.11%	21.10%	106.92%	49.64%	-65.75%	245.64%	-515.33%
Net Income Growth	85.60%	-159.65%	-37.80%	-74.30%	-257.89%	-14.87%	-339.74%	-1,465.84%	-308.58%	-256.14%	1,485.09%
EPS Growth	84.15%	-209.09%	-44.44%	-77.27%	-256.52%	56.00%	-325.00%	-650.00%	-182.14%	-219.05%	500.00%
Operating Cash Flow Growth	-37.25%	8.40%	0.95%	-9.17%	10.06%	-12.85%	842.59%	163.16%	58.07%	134.21%	-80.60%
Free Cash Flow Firm Growth	37.63%	188.15%	50.23%	117.82%	118.48%	109.71%	117.12%	-470.88%	-2,356.12%	-452.93%	-2,993.01%
Invested Capital Growth	-15.94%	-19.38%	-14.74%	-11.86%	-10.39%	-6.69%	-8.94%	203.81%	96.05%	229.40%	108.18%
Revenue Q/Q Growth	-3.48%	-1.79%	-0.28%	-3.21%	-1.10%	-3.45%	1.22%	1.57%	-1.52%	10.35%	110.80%
EBITDA Q/Q Growth	44.44%	-15.30%	39.00%	235.99%	-134.76%	12.26%	8.23%	3.24%	-24.20%	-10.88%	211.37%
EBIT Q/Q Growth	118.87%	-46.46%	59.09%	67.16%	-1,256.48%	1,251.15%	89.63%	21.94%	-184.20%	-66.27%	277.05%
NOPAT Q/Q Growth	2,521.99%	2,145.69%	4.01%	104.49%	-1,973.95%	111.17%	-79.32%	359.66%	-39.68%	112.07%	-547.21%
Net Income Q/Q Growth	58.06%	-14.47%	35.22%	53.70%	-656.38%	39.25%	18.06%	4.94%	-142.77%	-226.78%	366.82%
EPS Q/Q Growth	61.76%	-30.77%	33.33%	52.44%	-645.45%	38.89%	18.18%	4.35%	8.00%	-412.50%	100.00%
Operating Cash Flow Q/Q Growth	-65.37%	15.68%	-29.05%	120.81%	-40.19%	7.73%	-36.16%	167.57%	-52.64%	1,065.16%	-82.18%
Free Cash Flow Firm Q/Q Growth	-20.88%	38.83%	21.40%	28.52%	33.03%	-27.62%	114.40%	-33.29%	30.06%	-27.53%	-411.95%
Invested Capital Q/Q Growth	-0.46%	-6.88%	-5.44%	-4.09%	-4.53%	-1.53%	-2.25%	-2.48%	-0.60%	-3.90%	226.14%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	61.55%	63.06%	61.88%	62.79%	62.95%	63.27%	61.54%	62.92%	63.34%	65.36%	63.29%
EBITDA Margin	55.25%	36.92%	42.81%	30.71%	-21.86%	62.18%	53.48%	50.01%	49.20%	63.92%	79.15%
Operating Margin	6.19%	80.63%	3.53%	3.38%	-72.86%	3.85%	1.76%	8.60%	1.90%	3.10%	-19.87%
EBIT Margin	3.15%	-16.12%	-10.81%	-26.35%	-77.64%	6.64%	-0.56%	-5.43%	-7.07%	8.27%	27.05%
Profit (Net Income) Margin	-15.18%	-34.93%	-29.97%	-46.14%	-96.46%	-12.61%	-20.04%	-24.76%	-26.46%	-10.73%	9.34%
Tax Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Interest Burden Percent	-481.73%	216.71%	277.28%	175.12%	124.23%	-189.94%	3,599.37%	455.65%	374.18%	-129.78%	34.53%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.52%	6.78%	0.29%	0.27%	-5.78%	0.30%	0.13%	0.98%	0.16%	0.25%	-1.38%
ROIC Less NNEP Spread (ROIC-NNEP)	-0.79%	0.41%	-1.92%	-2.93%	-8.86%	-0.75%	-1.33%	-2.14%	-2.14%	-1.10%	0.79%
Return on Net Nonoperating Assets (RNNOA)	-0.60%	0.30%	-1.40%	-2.12%	-6.11%	-0.50%	-0.89%	-1.51%	-1.60%	-0.72%	0.59%
Return on Equity (ROE)	-0.08%	7.08%	-1.11%	-1.84%	-11.89%	-0.20%	-0.75%	-0.53%	-1.44%	-0.47%	-0.79%
Cash Return on Invested Capital (CROIC)	17.59%	21.68%	14.62%	11.33%	9.83%	7.23%	9.65%	-101.07%	-65.11%	-107.14%	-70.61%
Operating Return on Assets (OROA)	0.34%	-1.76%	-1.14%	-2.75%	-8.04%	0.67%	-0.06%	-0.80%	-0.78%	0.85%	1.73%
Return on Assets (ROA)	-1.65%	-3.81%	-3.17%	-4.82%	-9.98%	-1.28%	-1.98%	-3.63%	-2.91%	-1.11%	0.60%
Return on Common Equity (ROCE)	-0.08%	6.98%	-1.09%	-1.82%	-11.72%	-0.19%	-0.74%	-0.52%	-1.42%	-0.47%	-0.78%
Return on Equity Simple (ROE_SIMPLE)	-7.76%	0.00%	-10.83%	-9.71%	-7.94%	0.00%	-3.95%	-2.50%	-1.22%	0.00%	1.30%
Net Operating Profit after Tax (NOPAT)	13	175	7.79	7.49	-167	8.89	4.21	20	4.43	7.34	-61
NOPAT Margin	4.33%	56.44%	2.47%	2.37%	-51.00%	2.69%	1.23%	6.02%	1.33%	2.17%	-19.87%
Net Nonoperating Expense Percent (NNEP)	1.31%	6.37%	2.21%	3.20%	3.08%	1.05%	1.46%	3.12%	2.30%	1.35%	-2.17%
Return On Investment Capital (ROIC_SIMPLE)	0.13%	1.76%	0.07%	0.07%	-1.44%	0.07%	0.03%	0.16%	0.03%	0.06%	-0.45%
Cost of Revenue to Revenue	38.45%	36.94%	38.12%	37.21%	37.05%	36.73%	38.46%	37.08%	36.66%	34.64%	36.71%
SG&A Expenses to Revenue	4.53%	11.04%	6.38%	4.43%	4.52%	4.42%	3.91%	4.57%	4.49%	4.26%	5.46%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	55.36%	-17.57%	58.36%	59.40%	135.81%	59.43%	59.78%	54.31%	61.44%	62.26%	83.15%
Earnings before Interest and Taxes (EBIT)	9.42	-50	-34	-83	-254	22	-1.91	-18	-24	28	83
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	165	114	135	97	-71	205	183	169	164	216	242
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.16	1.16	1.14	0.99	0.78	0.87	0.73	0.87	0.86	0.55	0.75
Price to Tangible Book Value (P/TBV)	1.33	1.33	1.31	1.14	0.89	1.03	0.88	1.04	1.02	0.65	0.87
Price to Revenue (P/Rev)	4.76	4.80	4.88	4.42	3.73	4.41	3.80	4.74	5.61	4.44	8.61
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	101.23	57.55
Dividend Yield	7.34%	7.45%	7.08%	7.94%	11.79%	7.93%	9.14%	35.58%	33.39%	32.13%	28.36%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.99%	1.74%
Enterprise Value to Invested Capital (EV/IC)	1.09	1.09	1.08	0.99	0.88	0.93	0.85	0.93	0.91	0.74	0.85
Enterprise Value to Revenue (EV/Rev)	8.23	8.10	8.44	8.08	7.36	8.12	7.49	8.61	10.14	9.88	16.52
Enterprise Value to EBITDA (EV/EBITDA)	19.95	37.34	29.72	25.67	20.26	15.13	13.83	14.31	16.26	14.22	21.63
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	164.31	104.22	48.38	58.20
Enterprise Value to NOPAT (EV/NOPAT)	368.67	438.29	0.00	0.00	0.00	287.99	278.49	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	21.57	20.48	22.17	21.71	19.44	21.84	19.52	27.42	38.19	33.78	58.54
Enterprise Value to Free Cash Flow (EV/FCFF)	5.65	4.49	6.77	8.22	8.49	12.46	8.42	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.92	0.88	0.88	0.86	0.79	0.75	0.74	0.73	0.72	0.70	0.71
Long-Term Debt to Equity	0.92	0.88	0.88	0.86	0.79	0.75	0.74	0.73	0.72	0.70	0.71
Financial Leverage	0.76	0.73	0.73	0.72	0.69	0.66	0.67	0.71	0.75	0.65	0.75
Leverage Ratio	1.95	1.90	1.92	1.90	1.85	1.81	1.83	1.90	1.89	1.84	1.90
Compound Leverage Factor	-9.42	4.13	5.31	3.33	2.30	-3.44	65.74	8.64	7.09	-2.38	0.66
Debt to Total Capital	47.88%	46.75%	46.93%	46.25%	43.98%	43.01%	42.37%	42.30%	41.80%	41.06%	41.54%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	47.88%	46.75%	46.93%	46.25%	43.98%	43.01%	42.37%	42.30%	41.80%	41.06%	41.54%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.69%	0.71%	0.80%	0.79%	0.78%	0.82%	0.85%	0.84%	0.84%	0.85%	0.83%
Common Equity to Total Capital	51.43%	52.54%	52.27%	52.96%	55.24%	56.17%	56.77%	56.86%	57.36%	58.09%	57.63%
Debt to EBITDA	9.24	16.93	13.52	12.41	10.51	7.24	7.14	6.75	7.66	8.26	10.89
Net Debt to EBITDA	8.27	14.96	12.32	11.41	9.82	6.77	6.66	6.29	7.12	7.66	10.13
Long-Term Debt to EBITDA	9.24	16.93	13.52	12.41	10.51	7.24	7.14	6.75	7.66	8.26	10.89
Debt to NOPAT	170.77	198.76	-34.75	-35.20	-38.35	137.85	143.80	-510.37	-251.70	-224.62	-141.51
Net Debt to NOPAT	152.85	175.63	-31.66	-32.35	-35.83	128.95	134.17	-475.66	-233.97	-208.33	-131.72
Long-Term Debt to NOPAT	170.77	198.76	-34.75	-35.20	-38.35	137.85	143.80	-510.37	-251.70	-224.62	-141.51
Altman Z-Score	0.19	0.21	0.24	0.19	0.55	0.72	0.60	0.69	0.70	0.46	0.61
Noncontrolling Interest Sharing Ratio	1.37%	1.40%	1.49%	1.46%	1.43%	1.44%	1.45%	1.13%	1.78%	1.12%	1.86%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.18	0.31	0.11	0.21	0.16	0.12	0.12	0.18	1.10	0.25	0.76
Quick Ratio	0.18	0.31	0.11	0.21	0.16	0.12	0.12	0.18	1.10	0.25	0.76
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,792	2,440	1,757	1,448	1,126	847	1,170	-8,125	-6,096	-8,716	-6,834
Operating Cash Flow to CapEx	138.26%	0.00%	0.00%	0.00%	152.66%	0.00%	0.00%	595.91%	0.00%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	32.69	41.70	28.98	23.18	18.45	13.40	17.66	-124.36	-95.60	-135.50	-126.24
Operating Cash Flow to Interest Expense	0.87	2.36	1.97	2.69	1.25	2.01	1.78	2.83	1.09	2.27	0.23
Operating Cash Flow Less CapEx to Interest Expense	0.24	9.88	7.75	6.47	0.43	6.12	3.81	2.36	2.00	6.00	11.71
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.11	0.11	0.11	0.10	0.10	0.10	0.10	0.15	0.11	0.10	0.06
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.14	0.14	0.13	0.13	0.13	0.13	0.12	0.18	0.14	0.13	0.08
Accounts Payable Turnover	3.03	2.18	2.39	2.51	3.14	2.19	2.28	3.40	2.60	2.08	1.33
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	120.29	167.49	152.86	145.48	116.33	166.30	160.36	107.26	140.63	175.13	273.83
Cash Conversion Cycle (CCC)	-120.29	-167.49	-152.86	-145.48	-116.33	-166.30	-160.36	-107.26	-140.63	-175.13	-273.83
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	9,379	9,423	10,119	10,702	11,158	11,688	11,869	12,142	12,451	12,526	13,034
Invested Capital Turnover	0.12	0.12	0.12	0.12	0.11	0.11	0.11	0.16	0.12	0.11	0.07
Increase / (Decrease) in Invested Capital	-1,779	-2,265	-1,750	-1,440	-1,293	-838	-1,166	8,145	6,100	8,723	6,773
Enterprise Value (EV)	10,208	10,271	10,882	10,633	9,851	10,915	10,123	11,324	11,388	9,215	11,067
Market Capitalization	5,907	6,084	6,286	5,820	4,988	5,927	5,141	6,240	6,296	4,140	5,770
Book Value per Share	$14.48	$14.77	$15.19	$15.55	$16.83	$17.91	$18.39	$18.85	$19.33	$19.89	$20.31
Tangible Book Value per Share	$12.67	$12.90	$13.21	$13.53	$14.69	$15.06	$15.39	$15.77	$16.20	$16.78	$17.37
Total Capital	9,875	9,964	10,551	11,117	11,615	12,147	12,336	12,626	12,829	13,034	13,409
Total Debt	4,728	4,658	4,952	5,142	5,108	5,225	5,227	5,340	5,362	5,352	5,570
Total Long-Term Debt	4,728	4,658	4,952	5,142	5,108	5,225	5,227	5,340	5,362	5,352	5,570
Net Debt	4,232	4,116	4,512	4,725	4,772	4,887	4,877	4,977	4,984	4,964	5,185
Capital Expenditures (CapEx)	35	-440	-351	-236	50	-259	-134	31	-59	-240	-621
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-145	-223	-205	-198	-163	-212	-205	-196	-35	-244	-112
Debt-free Net Working Capital (DFNWC)	-120	-154	-183	-156	-137	-186	-180	-160	15	-183	-55
Net Working Capital (NWC)	-120	-154	-183	-156	-137	-186	-180	-160	15	-183	-55
Net Nonoperating Expense (NNE)	58	283	102	153	149	51	73	104	93	44	-89
Net Nonoperating Obligations (NNO)	4,233	4,117	4,520	4,727	4,651	4,765	4,760	4,856	4,984	4,844	5,195
Total Depreciation and Amortization (D&A)	156	164	169	180	182	184	185	187	187	188	160
Debt-free, Cash-free Net Working Capital to Revenue	-11.71%	-17.54%	-15.93%	-15.02%	-12.20%	-15.78%	-15.17%	-14.91%	-3.07%	-26.17%	-16.74%
Debt-free Net Working Capital to Revenue	-9.64%	-12.11%	-14.16%	-11.85%	-10.24%	-13.86%	-13.34%	-12.18%	1.37%	-19.63%	-8.14%
Net Working Capital to Revenue	-9.64%	-12.11%	-14.16%	-11.85%	-10.24%	-13.86%	-13.34%	-12.18%	1.37%	-19.63%	-8.14%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.13)	($0.34)	($0.26)	($0.39)	($0.82)	($0.11)	($0.18)	($0.22)	($0.23)	($0.25)	$0.08
Adjusted Weighted Average Basic Shares Outstanding	349.54M	365.55M	358.96M	372.48M	379.45M	378.93M	378.93M	378.90M	378.84M	252.36M	328.81M
Adjusted Diluted Earnings per Share	($0.13)	($0.34)	($0.26)	($0.39)	($0.82)	($0.11)	($0.18)	($0.22)	($0.23)	($0.25)	$0.08
Adjusted Weighted Average Diluted Shares Outstanding	349.54M	365.55M	358.96M	372.48M	379.45M	378.93M	378.93M	378.90M	378.84M	253.87M	332.03M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	351.42M	350.82M	354.39M	363.03M	378.54M	381.18M	380.87M	380.86M	380.82M	380.78M	380.57M
Normalized Net Operating Profit after Tax (NOPAT)	14	176	8.29	7.79	8.97	9.10	4.75	21	4.63	7.41	-42
Normalized NOPAT Margin	4.57%	56.80%	2.63%	2.46%	2.75%	2.76%	1.39%	6.16%	1.39%	2.19%	-13.80%
Pre Tax Income Margin	-15.18%	-34.93%	-29.97%	-46.14%	-96.46%	-12.61%	-20.04%	-24.76%	-26.46%	-10.73%	9.34%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.17	-0.85	-0.56	-1.33	-4.16	0.35	-0.03	-0.28	-0.37	0.43	1.53
NOPAT to Interest Expense	0.24	2.99	0.13	0.12	-2.73	0.14	0.06	0.31	0.07	0.11	-1.12
EBIT Less CapEx to Interest Expense	-0.46	6.67	5.22	2.45	-4.97	4.45	2.00	-0.76	0.55	4.17	13.01
NOPAT Less CapEx to Interest Expense	-0.39	10.51	5.91	3.90	-3.55	4.25	2.09	-0.16	0.99	3.85	10.35
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-115.20%	-69.79%	-78.85%	-83.43%	-93.77%	-169.23%	233.62%	-239.76%	-399.46%	701.37%	1,331.67%
Augmented Payout Ratio	-247.23%	-148.12%	-149.91%	-131.35%	-93.95%	-170.04%	232.13%	-242.09%	-404.00%	709.21%	1,334.35%

Frequently Asked Questions About Healthcare Realty Trust's Financials

When does Healthcare Realty Trust's financial year end?

According to the most recent income statement we have on file, Healthcare Realty Trust's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Healthcare Realty Trust's net income changed over the last 9 years?

Healthcare Realty Trust's net income appears to be on an upward trend, with a most recent value of -$663.90 million in 2024, falling from $33.56 million in 2015. The previous period was -$282.08 million in 2023. See where experts think Healthcare Realty Trust is headed by visiting Healthcare Realty Trust's forecast page.

What is Healthcare Realty Trust's operating income?

Healthcare Realty Trust's total operating income in 2024 was $33.48 million, based on the following breakdown:

Total Gross Profit: $794.87 million
Total Operating Expenses: $761.40 million

How has Healthcare Realty Trust revenue changed over the last 9 years?

Over the last 9 years, Healthcare Realty Trust's total revenue changed from $403.82 million in 2015 to $1.27 billion in 2024, a change of 214.1%.

How much debt does Healthcare Realty Trust have?

Healthcare Realty Trust's total liabilities were at $5.35 billion at the end of 2024, a 6.5% decrease from 2023, and a 203.5% increase since 2015.

How much cash does Healthcare Realty Trust have?

In the past 8 years, Healthcare Realty Trust's cash and equivalents has ranged from $11.23 million in 2016 to $126.22 million in 2018, and is currently $68.92 million as of their latest financial filing in 2024.

How has Healthcare Realty Trust's book value per share changed over the last 9 years?

Over the last 9 years, Healthcare Realty Trust's book value per share changed from 10.86 in 2015 to 14.77 in 2024, a change of 36.0%.

Related Companies

This page (NYSE:HR) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Healthcare Realty Trust (HR) Financials

Frequently Asked Questions About Healthcare Realty Trust's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Healthcare Realty Trust (HR) Financials

Annual Income Statements for Healthcare Realty Trust

Quarterly Income Statements for Healthcare Realty Trust

Annual Cash Flow Statements for Healthcare Realty Trust

Quarterly Cash Flow Statements for Healthcare Realty Trust

Annual Balance Sheets for Healthcare Realty Trust

Quarterly Balance Sheets for Healthcare Realty Trust

Annual Metrics And Ratios for Healthcare Realty Trust

Quarterly Metrics And Ratios for Healthcare Realty Trust

Frequently Asked Questions About Healthcare Realty Trust's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools